Fingerprint
Dive into the research topics where Winston Tan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A pilot single-arm, pragmatic trial in progress of in-home versus in-clinic subcutaneous nivolumab administration through Cancer Care (connected access and remote expertise) Beyond Walls (CCBW) program.
Elantably, D., Jones, J. C., Lou, Y., Mazza, G., Howard, C., Confiado, S., Baskin, A., Jackson, A., Fritsche, A. H., Lopez, K., Brown, J., Nolan, L., Chapin, D., Beliles, G., Smith, N., Tan, W., Kharfan-Dabaja, M., Nowakowski, G. S., Willman, C. & Dronca, R. S., 2025, In: Journal of Clinical Oncology. 43, 16, p. TPS1657-TPS1657Research output: Contribution to journal › Article › peer-review
-
A real-world experience of pembrolizumab monotherapy in microsatellite instability-high and/or tumor mutation burden-high metastatic castration-resistant prostate cancer: outcome analysis
Mosalem, O., Tan, W., Bryce, A. H., Dronca, R. S., Childs, D. S., Pagliaro, L. C., Orme, J. J. & Kase, A. M., Mar 2025, In: Prostate Cancer and Prostatic Diseases. 28, 1, p. 138-144 7 p., 34.Research output: Contribution to journal › Article › peer-review
-
Have We Made Progress? Interprofessional Diversity Within Faculty and Course Directors of Continuous Professional Development Courses Pre-and Post-Joint Accreditation
Ness, B., Herndon, J., Hoffmann, C., Benysh, S., Bowler, C. & Tan, W., 2025, In: Advances in Medical Education and Practice. 16, p. 607-613 7 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Myeloid targeting antibodies PY159 and PY314 for platinum-resistant ovarian cancer
Yeku, O. O., Barve, M., Tan, W. W., Wang, J., Patnaik, A., LoRusso, P., Richardson, D. L., Naqash, A. R., Lynam, S. K., Fu, S., Gordon, M., Hubbard, J., Kummar, S., Kyriakopoulos, C., Dowlati, A., Chamberlain, M. & Winer, I., Mar 13 2025, In: Journal for ImmunoTherapy of Cancer. 13, 3, e010959.Research output: Contribution to journal › Article › peer-review
Open Access -
A phase 1b open-label study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of py314 in combination with pembrolizumab in patients with advanced renal cell carcinoma
Beckermann, K. E., Patnaik, A., Winer, I., Tan, W., Bashir, B., Kyriakopoulos, C. E., Sweis, R. F., Chamberlain, M. & Rini, B. I., Apr 2024, In: Investigational New Drugs. 42, 2, p. 179-184 6 p.Research output: Contribution to journal › Article › peer-review